Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group
Stavros Chrysidis, Christina Duftner, Christian Dejaco, et al.
RMD Open (2018) Vol. 4, Iss. 1, pp. e000598-e000598
Open Access | Times Cited: 201

Showing 1-25 of 201 citing articles:

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco, Sofía Ramiro, Christina Duftner, et al.
Annals of the Rheumatic Diseases (2018) Vol. 77, Iss. 5, pp. 636-643
Open Access | Times Cited: 880
2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
Cristina Ponte, Peter C. Grayson, Joanna Robson, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1647-1653
Open Access | Times Cited: 217
OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On
George A W Bruyn, Annamaria Iagnocco, Esperanza Naredo, et al.
The Journal of Rheumatology (2019) Vol. 46, Iss. 10, pp. 1388-1393
Open Access | Times Cited: 199
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
Sarah Mackie, Christian Dejaco, Simone Appenzeller, et al.
Lara D. Veeken (2020) Vol. 59, Iss. 3, pp. e1-e23
Open Access | Times Cited: 178
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update
Christian Dejaco, Sofía Ramiro, Milena Bond, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 6, pp. 741-751
Open Access | Times Cited: 160
2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis
Cristina Ponte, Peter C. Grayson, Joanna Robson, et al.
Arthritis & Rheumatology (2022) Vol. 74, Iss. 12, pp. 1881-1889
Open Access | Times Cited: 100
Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica
Eugenio de Miguel, Pierluigi Macchioni, Edoardo Conticini, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 1, pp. 158-164
Closed Access | Times Cited: 43
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
Kornelis S. M. van der Geest, Frances Borg, Abdul Kayani, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 3, pp. 393-399
Open Access | Times Cited: 106
Diagnosis of giant cell arteritis
Cristina Ponte, Joana Martins-Martinho, Raashid Luqmani
Lara D. Veeken (2019) Vol. 59, Iss. Supplement_3, pp. iii5-iii16
Open Access | Times Cited: 101
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica
Dario Camellino, Eric L. Matteson, Frank Buttgereit, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 9, pp. 481-495
Closed Access | Times Cited: 70
The provisional OMERACT ultrasonography score for giant cell arteritis
Christian Dejaco, Cristina Ponte, Sara Monti, et al.
Annals of the Rheumatic Diseases (2022) Vol. 82, Iss. 4, pp. 556-564
Open Access | Times Cited: 53
Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study
Berit Dalsgaard Nielsen, Philip Therkildsen, Kresten Krarup Keller, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 9, pp. 3084-3094
Closed Access | Times Cited: 27
Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica – a prospective cohort study
L. C. Burg, Pantelis Karakostas, Charlotte Behning, et al.
Therapeutic Advances in Musculoskeletal Disease (2023) Vol. 15
Open Access | Times Cited: 25
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
J. Molina Collada, Isabel Castrejón, I. Monjo, et al.
RMD Open (2023) Vol. 9, Iss. 2, pp. e002970-e002970
Open Access | Times Cited: 21
Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a prospective multicentre study
Alwin Sebastian, Kornelis S. M. van der Geest, Alessandro Tomelleri, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 5, pp. e291-e299
Closed Access | Times Cited: 9
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis
Lisa Ehlers, Johan Askling, Hans WJ Bijlsma, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 9, pp. 1160-1166
Open Access | Times Cited: 63
Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises
Valentin Sebastian Schäfer, Stavros Chrysidis, Christian Dejaco, et al.
The Journal of Rheumatology (2018) Vol. 45, Iss. 9, pp. 1289-1295
Open Access | Times Cited: 62
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides
Valentin Sebastian Schäfer, Lei Jin, Wolfgang Schmidt
Current Rheumatology Reports (2020) Vol. 22, Iss. 11
Open Access | Times Cited: 62
Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference
Berit Dalsgaard Nielsen, Ib Tønder Hansen, Kresten Krarup Keller, et al.
Lara D. Veeken (2019) Vol. 59, Iss. 8, pp. 2062-2073
Open Access | Times Cited: 60
The cut-off values for the intima–media complex thickness assessed by colour Doppler sonography in seven cranial and aortic arch arteries
Rok Ješe, Žiga Rotar, Matija Tomšič, et al.
Lara D. Veeken (2020) Vol. 60, Iss. 3, pp. 1346-1352
Closed Access | Times Cited: 57
S2k-Leitlinie: Management der Großgefäßvaskulitiden
Jan Henrik Schirmer, Peer Aries, K. Balzer, et al.
Zeitschrift für Rheumatologie (2020) Vol. 79, Iss. S3, pp. 67-95
Open Access | Times Cited: 51
Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
Luca Seitz, Lisa Christ, Fabian Lötscher, et al.
Lara D. Veeken (2021) Vol. 60, Iss. 11, pp. 5052-5059
Open Access | Times Cited: 46
The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
Lena Kreis, Christian Dejaco, Wolfgang Schmidt, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5
A direct comparison in diagnostic performance of CDUS, FDG-PET/CT and MRI in patients suspected of giant cell arteritis
Marieke van Nieuwland, Edgar M. Colin, Marloes Vermeer, et al.
Lara D. Veeken (2024)
Closed Access | Times Cited: 5
Reliability of the OMERACT Giant cell arteritis Ultrasonography Score (OGUS): results of a patient-based exercise involving experts and non-experts in vascular ultrasonography
Christina Duftner, Norbert Redlinger, George A. W. Bruyn, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e004667-e004667
Open Access
Page 1 - Next Page

Scroll to top